Navigation Links
Elsevier Launches New Open Access Journal: Photoacoustics

MUNICH, November 13, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of the new open access journal Photoacoustics.

The aim of Photoacoustics is to publish original research and review contributions within the fast growing scientific field of photoacoustics (optoacoustics) and thermoacoustics. Research in this area exploits optically and electromagnetically excited acoustical and thermal phenomena for visualization and characterization of a variety of materials and biological tissues, including living organisms.

Research directions employing photoacoustics are revolutionizing the ways that optical sensing and imaging are applied. Imaging based on photoacoustic techniques is considered the fastest growing bio-imaging modality. Likewise, photoacoustic sensing of tissues and cells, environmental and industrial measurements, spectroscopic detection and applications in nanotechnology and nanomedicine experience an unprecedented growth. In parallel, novel technologies including novel light sources, advanced ultrasonic detectors, novel contrast generation approaches and data processing and inversion methods are advancing to enable more accurate and quantitative use of photoacoustic techniques. Overall, photoacoustic techniques are expected to shape the future of optical methods and bring significant new performance in sensing and imaging sciences.

Founder and Editor-in-Chief of Photoacoustics, Professor Vasilis Ntziachristos, from the Technische Universität München and the Helmholtz Zentrum München, together with Section Editors Professor Daniel Razansky, Professor Stanislav Emelianov and Professor Sanjiv Sam Gambhir, and a highly accredited international Editorial Board, aim for the journal to not only contribute as a medium to report on exciting progress in the field, but also as means to develop a society of scientists with interests in the development and application of the technology.

"Photoacoustics is an exciting and fast growing field of research that needs dedicated representation to support growth and encourage impact on different applications," said Professor Vasilis Ntziachristos. "This is a time of change for the optical method. And it is time for a journal that captures all the exciting developments in this highly promising field."

Articles published in Photoacoustics are published open access; first publications are now available online on ScienceDirect.

For more information or to submit an article, go to Photoacoustics.

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,500 established peer-reviewed journals as well as 67 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact

Frauke Muenzel
Elsevier GmbH


SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Appoints New President of Elsevier CPM Resource Center
2. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
3. Elsevier Launches Second Annual Mosbys Superheroes of Nursing Contest During Nurses Week 2012
4. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
5. Elsevier Adds New Respiratory Care Collection to Mosbys Skills
6. Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
7. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
8. Elsevier Announces New Editor-In-Chief for Neurobiology of Learning and Memory
9. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
10. Elsevier Launches New Journal: Discourse, Context and Media
11. Elsevier Acquires Atira, a Provider of Research Management Solutions
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):